Trabectedin in the treatment of soft tissue sarcoma: Real‐world data on effectiveness, safety, and financial implications from a European comprehensive cancer center
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70403 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Jean-Stéphane Giraud und 10 weiteren Autor:innen. Beteiligte Einrichtung: Département de Pharmacie, Institut Curie, PSL Research University, Paris, France. Hauptthemen laut MEDLINE: Trabectedin, Sarcoma, Antineoplastic Agents, Alkylating. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Soft‐tissue sarcomas (STS) comprise over 150 histological subtypes, with advanced cases showing poor prognosis (5‐year survival
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de Pharmacie, Institut Curie, PSL Research University, Paris, France.
- Institut Cochin, Inserm U1016, CNRS UMR8104, Université Paris Cité, CARPEM, Paris, France.
- Department d'Oncologie Médicale, Institut Curie, PSL Research University, Paris, France.
- Université Paris Cité, CiTCoM, CNRS UMR 8038, Inserm U1268, Paris, France.
- Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France.
- Département de Médecine Diagnostique et Théranostique, Institut Curie, PSL Research University, Paris, France.
ORCID-Profile: Jean-Stéphane Giraud, Sarah Watson
Zitieren
APA
Giraud, J. S., Watson, S., Acramel, A., Laurence, V., Tzanis, D., Bonvalot, S., El Zein, S., Nicolas, N., Cros, C., Desmaris, R., & Bonnet, C. (2026). Trabectedin in the treatment of soft tissue sarcoma: Real‐world data on effectiveness, safety, and financial implications from a European comprehensive cancer center. International Journal of Cancer. https://doi.org/10.1002/ijc.70403
Vancouver
Giraud JS, Watson S, Acramel A, Laurence V, Tzanis D, Bonvalot S, et al. Trabectedin in the treatment of soft tissue sarcoma: Real‐world data on effectiveness, safety, and financial implications from a European comprehensive cancer center. International Journal of Cancer. 2026. doi:10.1002/ijc.70403
BibTeX
@article{Giraud2026,
author = {Giraud, Jean-Stéphane and Watson, Sarah and Acramel, Alexandre and Laurence, Valérie and Tzanis, Dimitri and Bonvalot, Sylvie and El Zein, Sophie and Nicolas, Nayla and Cros, Cyrille and Desmaris, Romain and Bonnet, Clément},
title = {Trabectedin in the treatment of soft tissue sarcoma: Real‐world data on effectiveness, safety, and financial implications from a European comprehensive cancer center},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70403}
}
EUVIMED